- Home
- ORGO vs JFIN Comparison
ORGO vs JFIN Comparison
Compare ORGO & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- JFIN
- Stock Information
- Founded
- ORGO 1985
- JFIN 2011
- Country
- ORGO United States
- JFIN China
- Employees
- ORGO N/A
- JFIN N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- JFIN Finance: Consumer Services
- Sector
- ORGO Health Care
- JFIN Finance
- Exchange
- ORGO Nasdaq
- JFIN Nasdaq
- Market Cap
- ORGO 620.3M
- JFIN 547.0M
- IPO Year
- ORGO N/A
- JFIN 2019
- Fundamental
- Price
- ORGO $4.07
- JFIN $10.06
- Analyst Decision
- ORGO Buy
- JFIN
- Analyst Count
- ORGO 3
- JFIN 0
- Target Price
- ORGO $7.33
- JFIN N/A
- AVG Volume (30 Days)
- ORGO 765.7K
- JFIN 77.1K
- Earning Date
- ORGO 11-06-2025
- JFIN 11-19-2025
- Dividend Yield
- ORGO N/A
- JFIN 7.92%
- EPS Growth
- ORGO N/A
- JFIN 33.85
- EPS
- ORGO N/A
- JFIN 4.21
- Revenue
- ORGO $429,531,000.00
- JFIN $908,895,698.00
- Revenue This Year
- ORGO $2.51
- JFIN N/A
- Revenue Next Year
- ORGO $25.45
- JFIN N/A
- P/E Ratio
- ORGO N/A
- JFIN $2.42
- Revenue Growth
- ORGO N/A
- JFIN 8.19
- 52 Week Low
- ORGO $2.61
- JFIN $5.18
- 52 Week High
- ORGO $6.71
- JFIN $19.23
- Technical
- Relative Strength Index (RSI)
- ORGO 40.27
- JFIN 33.28
- Support Level
- ORGO $3.84
- JFIN $10.00
- Resistance Level
- ORGO $4.40
- JFIN $11.64
- Average True Range (ATR)
- ORGO 0.22
- JFIN 0.47
- MACD
- ORGO -0.03
- JFIN 0.00
- Stochastic Oscillator
- ORGO 26.79
- JFIN 4.88
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.